Orthofix earns FDA clearance for Rodeo telescopic nail

Orthofix earned FDA 510(k) clearance for its Rodeo telescopic nail, the devicemaker said May 9.

Advertisement

The Rodeo nail is indicated to treat deformities or fractures in patients with osteogenesis imperfecta, according to a news release. It is designed to address biomechanical and procedural challenges associated with OI rod systems and comes with sterilized instrument packs.

The nail will be available in the U.S. in the near future, and has been used in more than 170 clinical cases in Europe.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.